|
Originally published In Press as doi:10.1074/jbc.M202959200 on July 8, 2002
J. Biol. Chem., Vol. 277, Issue 38, 35766-35775, September 20, 2002
Interferons Inhibit Tumor Necrosis Factor- -mediated
Matrix Metalloproteinase-9 Activation via Interferon Regulatory
Factor-1 Binding Competition with NF- B*
Josiane
Sancéau ,
Douglas D.
Boyd§,
Motoharu
Seiki¶, and
Brigitte
Bauvois
From the Unité 365 INSERM, Section de
Recherche, Institut Curie, 75248 Paris Cedex 05, France,
§ Department of Cancer Biology, MD Anderson Cancer Center,
Houston, Texas 77030, and ¶ Department of Cancer Cell Research,
Institute of Medical Science, the University of Tokyo 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan
Enhanced expression of matrix
metalloproteinase-9 (MMP-9) correlates with invasion during tumor
progression. Interferons (IFNs) inhibit MMP-9 activation in response to
tumor necrosis factor- (TNF- ), and the latter activates the
MMP-9 gene through NF- B. Understanding the molecular
basis for MMP-9 inhibition may provide tools to control cell invasion.
The data reported here show the critical role of interferon regulatory
factor-1 (IRF1) in the inhibition of MMP-9. (i) IFN treatment
suppresses TNF- -induced MMP-9 reporter activity in STAT1(+/+) cells
but not in STAT1( / ) cells. (ii) IRF1 transfection blocks
TNF- -mediated MMP-9 activation. (iii) IFNs phosphorylate STAT1 and
induce IRF1 but do not affect I -B degradation nor NF- B nuclear
translocation. (iv) Nuclear NF- B (p50/p65) and IRF1, but not STAT1,
bind to the MMP-9 promoter region containing an
IFN-responsive-like element overlapping the NF- B-binding site. (v)
Recombinant IRF1, although unable to bind to an NF- B consensus
sequence, competes with NF- B proteins for binding to the
MMP-9 promoter. (vi) Conversely recombinant p50/p65 proteins reduce IRF1-DNA binding. (vii) In cells cotransfected with
IRF1 and/or p65 expression vectors, an excess of IRF1 reduces MMP-9
reporter activity, whereas an excess of p65 blocks the inhibitory effect of IFN- . Thus, in contrast to the known synergism between IRF1 and NF- B, our data identify a novel role for IRF1 as a
competitive inhibitor of NF- B binding to the particular
MMP-9 promoter context.
*
This work was supported by grants from INSERM and Grant 5424 from the Association pour la Recherche sur le Cancer.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Unité 365 INSERM, Institut Curie, Pavillon Pasteur, 26 Rue d'Ulm, 75248 Paris Cedex 05, France. Tel.: 01-42-34-67-11; Fax: 01-44-07-07-85; E-mail: Brigitte.Bauvois@curie.fr.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Rylski, R. Amborska, K. Zybura, B. Mioduszewska, P. Michaluk, J. Jaworski, and L. Kaczmarek
Yin Yang 1 Is a Critical Repressor of Matrix Metalloproteinase-9 Expression in Brain Neurons
J. Biol. Chem.,
December 12, 2008;
283(50):
35140 - 35153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Qin, L. Liao, A. Redmond, L. Young, Y. Yuan, H. Chen, B. W. O'Malley, and J. Xu
The AIB1 Oncogene Promotes Breast Cancer Metastasis by Activation of PEA3-Mediated Matrix Metalloproteinase 2 (MMP2) and MMP9 Expression
Mol. Cell. Biol.,
October 1, 2008;
28(19):
5937 - 5950.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Tliba and Y. Amrani
Airway Smooth Muscle Cell as an Inflammatory Cell: Lessons Learned from Interferon Signaling Pathways
Proceedings of the ATS,
January 1, 2008;
5(1):
106 - 112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Harris, M. Fernandez-Vilaseca, P. T. G. Elkington, D. E. Horncastle, M. B. Graeber, and J. S. Friedland
IFN{gamma} synergizes with IL-1{beta} to up-regulate MMP-9 secretion in a cellular model of central nervous system tuberculosis
FASEB J,
February 1, 2007;
21(2):
356 - 365.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Keslacy, O. Tliba, H. Baidouri, and Y. Amrani
Inhibition of Tumor Necrosis Factor-{alpha}-Inducible Inflammatory Genes by Interferon-{gamma} Is Associated with Altered Nuclear Factor-{kappa}B Transactivation and Enhanced Histone Deacetylase Activity
Mol. Pharmacol.,
February 1, 2007;
71(2):
609 - 618.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ichikawa, M. S. Nair, Y. Takada, D.B. A. Sheeja, M.A. S. Kumar, O. V. Oommen, and B. B. Aggarwal
Isodeoxyelephantopin, a Novel Sesquiterpene Lactone, Potentiates Apoptosis, Inhibits Invasion, and Abolishes Osteoclastogenesis through Suppression of Nuclear Factor-{kappa}B (NF-{kappa}B) Activation and NF-{kappa}B-Regulated Gene Expression.
Clin. Cancer Res.,
October 1, 2006;
12(19):
5910 - 5918.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. E. Battle, R. A. Lynch, and D. A. Frank
Signal transducer and activator of transcription 1 activation in endothelial cells is a negative regulator of angiogenesis.
Cancer Res.,
April 1, 2006;
66(7):
3649 - 3657.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Aggarwal, H. Ichikawa, Y. Takada, S. K. Sandur, S. Shishodia, and B. B. Aggarwal
Curcumin (Diferuloylmethane) Down-Regulates Expression of Cell Proliferation and Antiapoptotic and Metastatic Gene Products through Suppression of I{kappa}B{alpha} Kinase and Akt Activation
Mol. Pharmacol.,
January 1, 2006;
69(1):
195 - 206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-H. Wu, Y. Shoji, M.-C. Wu, P.-C. Chuang, C.-C. Lin, M.-F. Huang, and S.-J. Tsai
Suppression of Matrix Metalloproteinase-9 by Prostaglandin E2 in Peritoneal Macrophage Is Associated with Severity of Endometriosis
Am. J. Pathol.,
October 1, 2005;
167(4):
1061 - 1069.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ray, B. S. Bal, and B. K. Ray
Transcriptional Induction of Matrix Metalloproteinase-9 in the Chondrocyte and Synoviocyte Cells Is Regulated via a Novel Mechanism: Evidence for Functional Cooperation between Serum Amyloid A-Activating Factor-1 and AP-1
J. Immunol.,
September 15, 2005;
175(6):
4039 - 4048.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Ma, M. J. Chang, R. C. Shah, and E. N. Benveniste
Interferon-{gamma}-activated STAT-1{alpha} suppresses MMP-9 gene transcription by sequestration of the coactivators CBP/p300
J. Leukoc. Biol.,
August 1, 2005;
78(2):
515 - 523.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ichikawa, Y. Takada, A. Murakami, and B. B. Aggarwal
Identification of a Novel Blocker of I{kappa}B{alpha} Kinase That Enhances Cellular Apoptosis and Inhibits Cellular Invasion through Suppression of NF-{kappa}B-Regulated Gene Products
J. Immunol.,
June 1, 2005;
174(11):
7383 - 7392.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Carotenuto, D. van Riel, A. Artsen, S. Bruijns, F. G. Uytdehaag, J. D. Laman, A. B. van Nunen, P. E. Zondervan, R. A. De Man, A. D. Osterhaus, et al.
Antiviral Treatment with Alpha Interferon Up-Regulates CD14 on Liver Macrophages and Its Soluble Form in Patients with Chronic Hepatitis B
Antimicrob. Agents Chemother.,
February 1, 2005;
49(2):
590 - 599.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Shan, Y. Zhuo, D. Chin, C. A. Morris, G. F. Morris, and J. A. Lasky
Cyclin-dependent Kinase 9 Is Required for Tumor Necrosis Factor-{alpha}-stimulated Matrix Metalloproteinase-9 Expression in Human Lung Adenocarcinoma Cells
J. Biol. Chem.,
January 14, 2005;
280(2):
1103 - 1111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Karmakar, R. Dhar, and C. Das
Inhibition of Cytotrophoblastic (JEG-3) Cell Invasion by Interleukin 12 Involves an Interferon {gamma}-mediated Pathway
J. Biol. Chem.,
December 31, 2004;
279(53):
55297 - 55307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Liuzzi, T. Latronico, A. Fasano, G. Carlone, and P. Riccio
Interferon-beta inhibits the expression of metalloproteinases in rat glial cell cultures: implications for multiple sclerosis pathogenesis and treatment
Multiple Sclerosis,
June 1, 2004;
10(3):
290 - 297.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Tliba, S. Tliba, C. Da Huang, R. K. Hoffman, P. DeLong, R. A. Panettieri Jr., and Y. Amrani
Tumor Necrosis Factor {alpha} Modulates Airway Smooth Muscle Function via the Autocrine Action of Interferon {beta}
J. Biol. Chem.,
December 12, 2003;
278(50):
50615 - 50623.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zhou, Y. Zhang, J. A. Ardans, and L. M. Wahl
Interferon-{gamma} Differentially Regulates Monocyte Matrix Metalloproteinase-1 and -9 through Tumor Necrosis Factor-{alpha} and Caspase 8
J. Biol. Chem.,
November 14, 2003;
278(46):
45406 - 45413.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sanceau, S. Truchet, and B. Bauvois
Matrix Metalloproteinase-9 Silencing by RNA Interference Triggers the Migratory-adhesive Switch in Ewing's Sarcoma Cells
J. Biol. Chem.,
September 19, 2003;
278(38):
36537 - 36546.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Castrillo, S. B. Joseph, C. Marathe, D. J. Mangelsdorf, and P. Tontonoz
Liver X Receptor-dependent Repression of Matrix Metalloproteinase-9 Expression in Macrophages
J. Biol. Chem.,
March 14, 2003;
278(12):
10443 - 10449.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|